サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1592596

欧州の抗体探索市場の2030年までの予測 - 地域別分析：抗体タイプ別、性質別、サービス別、エンドユーザー別

Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日
ページ情報
英文 94 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州の抗体探索市場の2030年までの予測 - 地域別分析：抗体タイプ別、性質別、サービス別、エンドユーザー別
出版日: 2024年09月16日
発行: The Insight Partners
ページ情報: 英文 94 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の抗体探索市場は、2022年に8,244億4,111万米ドルとなり、2030年までには1兆3,294億8,160万米ドルに達すると予測され、2022年から2030年までのCAGRは6.2%と推定されます。

がん罹患率の上昇が欧州の抗体探索市場を牽引

2020年に発表されたGlobal Cancer Observatory（GLOBOCAN）の推計によると、世界中で1,930万人のがん患者が発生しています。2030年1月までに、がんサバイバーの人口は2,210万人に達すると推定されており、これは主に人口の高齢化に関連しています。肺がん、乳がん、大腸がん、前立腺がん、乳房がんなどが、最も多く報告されているがんの種類です。がん罹患率の増加は、世界中で懸念を呼んでいます。

がんは現在、不健康な食習慣や運動不足の人によく見られる生活習慣病です。アルコールやタバコの頻繁な摂取は、がん発症のリスクを高めます。中低所得国における慢性感染症は、がんの危険因子をさらに悪化させます。がんの罹患率の増加は、革新的ながん治療の必要性を示しています。モノクローナル抗体は、がん細胞の活性を抑制し、がん細胞を排除する免疫系の自然な能力を高める、有望な標的抗がん剤の一種です。抗体薬物複合体（ADC）もまた、がん治療において有望な結果を示しています。さらに、現代のバイオテクノロジーの進歩により、研究者や企業は優れた設計の新規抗体を提供できるようになり、さまざまな種類のがんの治療成功への道が開かれました。このように、さまざまな種類のがんの急増が抗体探索市場の成長を後押ししています。

欧州の抗体探索市場の概要

欧州の抗体探索市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。この地域は世界市場で大きなシェアを占めています。研究開発用途、がん治療、免疫疾患管理におけるモノクローナル抗体の利用が急増していることから、今後数年間は堅調な成長率を記録すると予想されます。さらに、患者データ管理システムに対するニーズの高まり、慢性疾患の流行、抗体サービスの導入に対する政府の取り組みなどが、フランス、イタリア、スペインなどの国々における抗体探索市場に成長機会をもたらすと期待されています。

欧州の抗体探索市場の収益と2030年までの予測（10億米ドル）

欧州の抗体探索市場のセグメンテーション

欧州の抗体探索市場は、抗体タイプ、性質、サービス、エンドユーザー、国に分類されます。

抗体タイプに基づき、欧州の抗体探索市場はモノクローナル抗体、ポリクローナル抗体、その他に区分されます。モノクローナル抗体セグメントは、2022年の欧州の抗体探索市場で最大のシェアを占めています。

性質別では、欧州の抗体探索市場はヒトおよびヒト化、キメラ、マウスに区分されます。ヒトおよびヒト化セグメントは2022年に欧州の抗体探索市場で最大のシェアを占めました。

サービス別では、欧州の抗体探索市場はファージディスプレイ、ハイブリドーマ、トランスジェニック動物、シングルセル、イーストディスプレイに分けられます。ファージディスプレイセグメントは2022年に欧州の抗体探索市場で最大のシェアを占めました。

エンドユーザー別に見ると、欧州の抗体探索市場は製薬・バイオテクノロジー企業、研究所、その他に分類されます。製薬・バイオテクノロジー企業セグメントが2022年に欧州の抗体探索市場で最大のシェアを占めました。

国別では、欧州の抗体探索市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に分類されます。2022年の欧州の抗体探索市場シェアはドイツが独占しました。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、Biocytogen Pharmaceuticals Beijing Co Ltd.は、欧州の抗体探索市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の抗体探索市場：要市場力学

  • 市場促進要因
    • 研究開発投資の増加
    • がん罹患率の上昇
  • 市場抑制要因
    • 生産コストの高さ
  • 市場機会
    • 発展途上地域におけるバイオテクノロジー産業の普及
  • 今後の動向
    • カスタム抗体の開発
  • 促進要因と抑制要因の影響

第5章 抗体探索市場：欧州市場分析

  • 欧州の抗体探索市場の収益、2020年～2030年

第6章 欧州の抗体探索市場の分析：抗体タイプ別

  • モノクローナル抗体
  • ポリクローナル抗体
  • その他

第7章 欧州の抗体探索市場の分析：性質別

  • ヒト・ヒト化抗体
  • キメラ
  • マウス

第8章 欧州の抗体探索市場の分析：サービス別

  • ファージディスプレイ
  • ハイブリドーマ
  • トランスジェニック動物
  • 酵母ディスプレイ
  • シングルセル

第9章 欧州の抗体探索市場の分析：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 研究機関
  • その他

第10章 欧州の抗体探索市場：国別分析

    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第11章 抗体探索市場：業界情勢

  • 抗体探索市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Europe Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Europe Antibody Discovery Market Segmentation, by Country
  • Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
  • Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Growth Strategies in the Antibody Discovery Market
目次
Product Code: BMIRE00030736

The Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030.

Rising Incidence of Cancer Drives Europe Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide.

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds up to the risk of developing cancer. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Europe Antibody Discovery Market Overview

The European antibody discovery market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global market. It is expected to register a robust growth rate in the coming years owing to the surging use of monoclonal antibodies in R&D applications, cancer therapies, and immunological disorder management. Further, the rising need for patient data management systems, the prevalence of chronic diseases, and government initiatives for the implementation of antibody services are expected to provide growth opportunities for the antibody discovery market in countries such as France, Italy, and Spain.

Europe Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Europe Antibody Discovery Market Segmentation

The Europe antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Europe antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Europe antibody discovery market share in 2022.

In terms of nature, the Europe antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Europe antibody discovery market share in 2022.

By services, the Europe antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Europe antibody discovery market share in 2022.

Based on end user, the Europe antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Europe antibody discovery market share in 2022.

Based on country, the Europe antibody discovery market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Europe antibody discovery market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Investments in Research & Development
    • 4.1.2 Rising Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Production
  • 4.3 Market Opportunities
    • 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
  • 4.4 Future Trends
    • 4.4.1 Developments for Custom Antibodies
  • 4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

  • 5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

  • 6.1 Overview
  • 6.2 Monoclonal Antibodies
    • 6.2.1 Overview
    • 6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Polyclonal Antibodies
    • 6.3.1 Overview
    • 6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

  • 7.1 Overview
  • 7.2 Human and Humanized
    • 7.2.1 Overview
    • 7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Chimeric
    • 7.3.1 Overview
    • 7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Murine
    • 7.4.1 Overview
    • 7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

  • 8.1 Overview
  • 8.2 Phage Display
    • 8.2.1 Overview
    • 8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Hybridoma
    • 8.3.1 Overview
    • 8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Transgenic Animal
    • 8.4.1 Overview
    • 8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Yeast Display
    • 8.5.1 Overview
    • 8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Single Cell
    • 8.6.1 Overview
    • 8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Research Laboratories
    • 9.3.1 Overview
    • 9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

  • 10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
    • 10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 UK
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.3 France
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Antibody Discovery Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Charles River Laboratories International Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Creative Biolabs Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Evotec SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Sartorius AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Aragen Life Sciences Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Twist Bioscience Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms